Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Are you a Dividend Trader
Learn how to make passive income from the best dividend stocks.
...
Health Services » Servicestothe Health Industry
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| CERN | Cerner Corporation | -0.24% | 67.85 | 7.6% | $119.39m | |
| DGX | Quest Diagnostics Incorporated | -0.56% | 104.38 | 4.2% | $99.32m | |
| LH | Laboratory Corporation of America Holdings | -0.29% | 172.30 | 2.3% | $83.95m | |
| SRCL | Stericycle, Inc. | -2.90% | 50.99 | 6.3% | $47.20m | |
| HMSY | HMS Holdings Corp. | 0.44% | 36.88 | 1.8% | $18.69m | |
| HCSG | Healthcare Services Group, Inc. | 0.27% | 25.70 | 6.7% | $18.47m | |
| OMCL | Omnicell, Inc. | 1.28% | 73.72 | 10.4% | $17.68m | |
| MDRX | Allscripts Healthcare Solutions, Inc. | 0.58% | 10.44 | 10.2% | $14.91m | |
| HSTM | HealthStream, Inc. | -0.11% | 26.49 | 6.7% | $5.46m | |
| CPSI | Computer Programs and Systems, Inc. | 0.80% | 24.00 | 32.3% | $2.96m | |
| BASI | Bioanalytical Systems, Inc. | -1.09% | 3.63 | 0.3% | $0.28m | |
| PMD | Psychemedics Corporation | 5.50% | 8.74 | 0.7% | $0.20m | |
| IDXG | Interpace Diagnostics Group, Inc. | 4.91% | 0.81 | 3.3% | $0.09m | |
| PLX | Protalix Biotherapeutics, Inc. | -3.17% | 0.22 | 5.8% | $0.05m | |
| STRM | Streamline Health Solutions, Inc. | -11.27% | 1.22 | 0.3% | $0.03m |
Company Profile
Protalix Biotherapeutics, Inc. engages in the development and commercialization of recombinant therapeutic proteins based on ProCellEx plant cell based expression system. It offers Taliglucerase alfa injections under the brand name Elelyso, an enzyme replacement therapy for Gaucher disease. The company's drugs also include Oral Glucocerebrosidase for potential treatment of Gaucher disease; therapeutic proteins for Fabry disease, and immune diseases such as rheumatoid, psoriatic and juvenile idiopathic arthritis, ankylosing, spondylitis, and plaque psoriasis; and protein for biodefense and other indications. Protalix Biotherapeutics was founded on November 30, 1995 and is headquartered in Carmiel, Israel.